Bupropion sustained release for the treatment of hypoactive sexual desire disorder in premenopausal women

被引：116

作者：

Segraves, RT

Clayton, A

Croft, H

Wolf, A

Warnock, J

机构：

[1] Case Western Reserve Univ, Dept Psychiat, Cleveland, OH 44109 USA

[2] MetroHlth Med Syst, Cleveland, OH USA

[3] Univ Virginia, Dept Psychiat, Charlottesville, VA USA

[4] Univ Oklahoma, Dept Psychiat, Oklahoma City, OK USA

来源：

JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY | 2004年 / 24卷 / 03期

关键词：

D O I：

10.1097/01.jcp.0000125686.20338.c1

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Premenopausal women meeting operational criteria for idiopathic, acquired, global hypoactive sexual desire disorder were studied in a randomized, double-blind, placebo-controlled, multiple-site escalating dose 112-day trial of bupropion sustained release. Outcome was measured by investigator-rating and self-administered questionnaires. All measures indicated greater sexual responsiveness in women receiving bupropion. The Changes in Sexual Functioning Questionnaire indicated that bupropion had significant effects on increasing measures of sexual arousal, orgasm completion, and sexual satisfaction.

引用

页码：339 / 342

页数：4

共 19 条

[1]

Balon R, 2003, SEXUAL PHARM FAST FA

[2] Female sexual response: The role of drugs in the management of sexual dysfunction [J].